Creative Planning’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.4M | Buy |
|
|||||
|
2025
Q2 | $5.08M | Sell |
|
|||||
|
2025
Q1 | $4.35M | Buy |
|
|||||
|
2024
Q4 | $2.54M | Buy |
|
|||||
|
2024
Q3 | $2.75M | Buy |
|
|||||
|
2024
Q2 | $1.95M | Buy |
|
|||||
|
2024
Q1 | $736K | Sell |
|
|||||
|
2023
Q4 | $971K | Buy |
|
|||||
|
2023
Q3 | $730K | Sell |
|
|||||
|
2023
Q2 | $941K | Buy |
|
|||||
|
2023
Q1 | $717K | Buy |
|
|||||
|
2022
Q4 | $775K | Buy |
|
|||||
|
2022
Q3 | $518K | Buy |
|
|||||
|
2022
Q2 | $368K | Buy |
|
|||||
|
2022
Q1 | $225K | Sell |
|
|||||
|
2021
Q4 | $291K | Buy |
|
|||||
|
2021
Q3 | $277K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1.54M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $83K | Buy |
|
|||||
|
2017
Q1 | $52K | Buy |
|
|||||
|
2016
Q4 | $26K | Buy |
|
|||||
|
2016
Q3 | $41K | Buy |
|
|||||
|
2016
Q2 | $4K | Hold |
|
|||||
|
2016
Q1 | $4K | Sell |
|
|||||
|
2015
Q4 | $63K | Hold |
|
|||||
|
2015
Q3 | $54K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $7K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $47K | Buy |
|